login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Showing Superbugs Turning Resistant To Antibiotics
An international team including scientists from the University of Edinburgh have mapped the complex molecular structure of an enzyme found in many bacteria.
These molecules - known as restriction enzymes - control the speed at which bacteria can acquire resistance to drugs and eventually become superbugs.
The study focused on E. coli, but the results would apply to many other infectious bacteria.
After prolonged treatment with antibiotics, bacteria may evolve to become resistant to many drugs, as is the case with superbugs such as MRSA.
Bacteria become resistant by absorbing DNA - usually from other bugs or viruses - which contains genetic information enabling the bacteria to block the action of drugs. Restriction enzymes can slow or halt this absorption process. Enzymes that work in this way are believed to have evolved as a defence mechanism for bacteria.
The researchers also studied the enzyme in action by reacting it with DNA from another organism. They were able to model the mechanism by which the enzyme disables the foreign DNA, while safeguarding the bacteria's own genetic material.
Restriction enzymes' ability to sever genetic material is widely applied by scientists to cut and paste strands of DNA in genetic engineering.
"We have known for some time that these enzymes are very effective in protecting bacteria from attack by other species. Now we have painted a picture of how this occurs, which should prove to be a valuable insight in tackling the spread of antibiotic-resistant superbugs," said Dr David Dryden, of the University of Edinburgh's School of Chemistry, who led the study.
The study was carried out in collaboration with the Universities of Leeds and Portsmouth with partners in Poland and France. It was supported by the Biotechnology and Biological Sciences Research Council and the Wellcome Trust and published in Genes and Development journal.
Source-ANI
|
|
More News on: MRSA - The Super Bug
 Comment & Contribute
|
Medwonders Health Network
- Health News Index
- News Quick Links
 | News Central | | Health Watch | |
| Latest Health News | | Health In Focus | |
| News Category (500+) | | Breaking Health News | |
| Popular News | | Celebrating Life | |
| Health News and Press Release | | Medindia - Exclusive | |
| News Photo Gallery | | India Special | |
| News Video Gallery | | Lifestyle and Wellness | |
| News From Other Resources | |||
| News Categories: |
| » | Individual Market Insurance Does Not Provide Coverage Equivalent to Even the Lowest Plan Available Under ACA |
| » | Report: A Lot of Americans Have No Access to Health Care |
| » | Greece Faces Humanitarian Crisis as Health Care Access Declines in EU, Doctors Group Warns |
| » | HCCI Report Says Rising Prices for Care Responsible for Increased Healthcare Costs for Privately Insured Americans |
| » | Treatment in ED is Based on Children's Insurance Status |
| More Insurance News | |
|
Drug Related News |
||||||||
| » | Drug for Irregular Heartbeat Gets Green Signal | » | Schizophrenia Drug Differentiates Cancer Stem Cells into Less Threatening Cells | |||||
| » | Docs Who Seldom Meet Drug Reps Continue to Prescribe Drugs With FDA “Black Box” Warnings | » | Revision in Quality Standards for Heparin | |||||
| » | Acne Drug Users At High Risk of Developing Eye Infections | » | Patients Who Take Antidepressants When in ICU More Likely to Die | |||||
| » | New Tablet Coating Product by Ideal Cures, In Geneva | » | Prednisolone Benefits Patients With Bell's Palsy | |||||
| Read More >> | ||||||||
